Recurrent heterozygous disruptions of the human TBR1 gene (including whole gene deletions, missense variants and truncating mutations) have been reported to cause neurodevelopmental disorders (NDDs), including autism spectrum disorder (ASD), intellectual disability (ID) and speech delay (OMIM 606053) (1–8). This evidence concerns the gene TBR1 and neurodevelopmental disorder.